Adrenal function of low-birthweight children

Area of Science:

• Endocrinology
• Neonatal Medicine
• Metabolic Health

Background:

• Low birthweight infants face increased stress, necessitating adequate adrenal cortisol secretion for survival.
• Transient cortisol insufficiency is common in early neonatal life for low birthweight infants, followed by normalization or elevation.
• Early life stress and low birthweight may program long-term alterations in adrenal hormone production.

Purpose of the Study:

• To investigate the long-term consequences of altered adrenal cortisol and androgen secretion in low birthweight survivors.
• To explore the link between early life adrenal function programming and later-life metabolic and cardiovascular health.
• To understand the role of adrenal hyperandrogenism in conditions like precocious pubarche and polycystic ovary syndrome.

Main Methods:

• This study is a review and synthesis of existing research on neonatal stress, low birthweight, and adrenal function.
• Analysis of hormonal profiles (cortisol and androgens) in low birthweight infants and long-term follow-up data.
• Correlation of early life adrenal activity with later development of hypertension, cardiovascular disease, and metabolic syndrome markers.

Main Results:

• Low birthweight and neonatal stress can lead to programming of higher cortisol secretion, potentially increasing later cardiovascular risk.
• Increased adrenal androgen secretion in low birthweight infants is linked to hyperandrogenism and hyperinsulinemia.
• Precocious pubarche in girls, a sign of adrenal hyperandrogenism, predicts polycystic ovary syndrome and metabolic disturbances.

Conclusions:

• Long-term effects of low birthweight impact both adrenal cortisol and androgen secretion.
• These hormonal changes contribute to an increased risk of developing metabolic syndrome later in life.
• Early life programming of adrenal function in low birthweight infants has significant implications for adult health.